1 day Ago By Defense World Staff
Bank of New York Mellon Corp lifted its stake in Scholar Rock Holding Co. ( NASDAQ:SRRK – Free Report ) by 17.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC.
The fund owned 230,450 shares of the company’s stock after acquiring an additional 33,468 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.29% of Scholar Rock worth $1,920,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in SRRK. Amalgamated Bank raised its position in shares of Scholar Rock by 15.5% in the fourth quarter.
Amalgamated Bank now owns 4,869 shares of the company’s stock valued at $92,000 after purchasing an additional 652 shares during the period. Walleye Trading LLC bought a new position in shares of Scholar Rock during the first quarter worth approximately $178,000. China Universal Asset Management Co.
Ltd. boosted its position in shares of Scholar Rock by 66.2% in the first quarter.
China Universal Asset Management Co. Ltd. now owns 13,868 shares of the company’s stock valued at $246,000 after acquiring an additional 5,522 shares during the period.
Bayesian Capital Management LP acquired a new position in shares of Scholar Rock in the first quarter valued at about $258,000. Finally, ProShare Advisors LLC grew its position in Scholar Rock by 11.7% during the first quarter.
ProShare Advisors LLC now owns 15,412 shares of the company’s stock worth $274,000 after buying an additional 1,620 shares in the last quarter. Institutional investors own 91.08% of the company’s stock.
Analysts Set New Price Targets SRRK has been the subject of several analyst reports. Wedbush reaffirmed an “outperform” rating and issued a $23.00 price objective on shares of Scholar Rock in a report on Thursday, August 8th.
HC Wainwright restated a “buy” rating and set a $30.00 target price on shares of Scholar Rock in a research note on Tuesday, June 25th. Finally, BMO Capital Markets lifted their price target on Scholar Rock from $31.
00 to $34.00 and gave the company an “outperform” rating in a research note on Friday, August 9th. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock.
Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $26.43. Scholar Rock Price Performance Shares of SRRK opened at $8.
24 on Wednesday. The stock has a market cap of $659.45 million, a PE ratio of -4.
12 and a beta of 0.82. The company has a quick ratio of 6.
04, a current ratio of 6.04 and a debt-to-equity ratio of 0.36.
The business has a 50-day simple moving average of $8.93 and a two-hundred day simple moving average of $11.39.
Scholar Rock Holding Co. has a 12-month low of $5.94 and a 12-month high of $21.
17. Scholar Rock ( NASDAQ:SRRK – Get Free Report ) last posted its earnings results on Thursday, August 8th. The company reported ($0.
60) EPS for the quarter, topping the consensus estimate of ($0.61) by $0.01.
During the same quarter last year, the company earned ($0.47) EPS. Analysts anticipate that Scholar Rock Holding Co.
will post -2.39 earnings per share for the current fiscal year. Scholar Rock Profile ( Free Report ) Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. See Also Five stocks we like better than Scholar Rock 3 Warren Buffett Stocks to Buy Now Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion? Business Services Stocks Investing Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge What is the S&P/TSX Index? Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter .
.
